CMPX EPS Estimates
Compass Therapeutics, Inc.
$0.76
+$0.07(+10.84%)
30
Overall
60
Value
9
Tech
21
Quality
Market Cap
$136.65M
Volume
1.85M
52W Range
$0.67 - $6.88
Target Price
$7.23
CMPX EPS estimates: the consensus estimate for Compass Therapeutics, Inc.'s current fiscal year is -$0.47 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
CMPX EPS Estimates
- EPS estimate, current quarter
- $-0.12
- EPS estimate, next quarter
- $-0.13
- EPS estimate, current year
- $-0.47
- EPS estimate, next year
- $-0.49
- EPS growth, 3-year
- -4.32%
| Fiscal year | EPS |
|---|---|
| 2025 | $-0.42 |
| 2024 | $-0.36 |
| 2023 | $-0.33 |
| 2022 | $-0.37 |
| 2021 | $-1.31 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CMPX | $0.76 | +10.8% | 1.85M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Compass Therapeutics, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW